Global and Regional Level Pharmaceutical Market Access Teams Plan Early to Develop Customized Launch Sequences
31 août 2017 15h41 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 31, 2017) - Surveyed teams at Top 10, Top 50 and small pharmaceutical companies each start their launch sequencing activities an average of at least...
About 67% of Global Market Access Teams Meet With Regulatory Groups Weekly When Approaching Product Launch
13 juil. 2017 08h45 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 13, 2017) - At least 67% of surveyed global market access teams meet with internal regulatory groups weekly in the six months before the first launch...
At Top Global Pharma Companies, Market Access Activities Begin at Least 16 Months Prior to Launch
30 mars 2017 10h18 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 30, 2017) - Surveyed Top 10 and Top 50 global companies begin pharmaceutical market access activities on average at least 16 months ahead of product...
US, Germany, and UK Among Most Common First Wave Markets in Launch Sequencing
08 févr. 2017 08h08 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - February 08, 2017) - Trends in pharmaceutical launch sequencing show the United States, Germany, and the United Kingdom among top first major wave markets,...
Pricing Studies Top Pharmaceutical Launch Sequence Spending at $130,000 Per New Product
31 janv. 2017 19h42 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - January 31, 2017) - Research published by Cutting Edge Information shows that the average spending on pricing studies for a single new product launch...
Drug Companies' Launch Sequencing Strategy Influences Approval Team Structure
18 oct. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 18, 2016) - Research conducted by Cutting Edge Information found that three-fourths of all surveyed pharmaceutical firms reported having ad hoc...
Top Pharma Executives Involved in Product Launch Sequencing Strategic Decisions
10 août 2016 09h14 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 10, 2016) - Some of the pharmaceutical industry's top executives are ultimately responsible for their products' launch sequences.According to a...
USA Remains Top Priority for Launching New Drugs
27 juil. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 27, 2016) - Follow the money. That's the approach that drug companies take when they arrange their new product launch sequences. A recent study...
Study Finds 88% of Pharma Companies Base Global Launch Planning on Regulatory Affairs Guidance
20 juil. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 20, 2016) - A new benchmarking study published by Cutting Edge Information discovered that regulatory guidance is the most common tool that...
77% of Surveyed Pharma Companies Use Ad Hoc Launch Sequencing Committees Instead of Dedicated Teams
30 juin 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 30, 2016) - While executing a new drug launch, 77% of surveyed pharmaceutical companies look to ad hoc launch sequencing groups rather than maintaining...